; (B) solicit and incorporate the input of the private sector, non-Federal partners, and stakeholders to increase communication and transparency, identify gaps of preparedness, and coordinate improvements in PHEMCE decision-making ; (C) aid in the PHEMCE’s strategic planning and decision-making regarding medical countermeasure research, advanced research, development, procurement, stockpiling, replenishment, deployment, and distribution; (D) aid in interactions among the PHEMCE’s members listed in subsection (b) and other government entities; and (E) aid in the PHEMCE’s communication of decisions related to the PHEMCE’s functions. (3) Membership The Secretary, in consultation with the members of the PHEMCE listed in subsection (b), shall appoint to the Advisory Committee at least 9, and not more than 11, individuals, including— (A) at least 3 non-Federal professionals with expertise in medical countermeasure development, including medical countermeasures for chemical, biological, radiological, or nuclear agents and emerging infectious diseases; (B) at least 2 non-Federal professionals with expertise in medical countermeasure stockpiling and replenishment; (C) at least 2 non-Federal professionals with expertise in the medical countermeasure supply chain, including medical countermeasure manufacturing and distribution; (D) at least 2 non-Federal professionals with expertise in medical disaster planning, preparedness, response, or recovery; (E) 1 non-Federal professional appointed by the Speaker of the House of Representatives; (F) 1 non-Federal professional appointed by the minority leader of the House of Representatives; (G) 1 non-Federal professional appointed by the majority leader of the Senate